# Mass Balance Study of [14C] TJ0113 in Healthy Chinese Subjects

> **NCT06832540** · PHASE1 · COMPLETED · sponsor: **Hangzhou PhecdaMed Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Chinese Subjects

## Interventions

- **DRUG:** [14C]TJ0113

## Key facts

- **NCT ID:** NCT06832540
- **Lead sponsor:** Hangzhou PhecdaMed Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-19
- **Primary completion:** 2025-03-05
- **Final completion:** 2025-03-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06832540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06832540, "Mass Balance Study of [14C] TJ0113 in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06832540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*